nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—MMP2—bile duct cancer	0.523	0.603	CbGaD
Captopril—MMP9—bile duct cancer	0.344	0.397	CbGaD
Captopril—F2—hepatic artery—bile duct cancer	0.0227	0.31	CbGeAlD
Captopril—F2—portal vein—bile duct cancer	0.0197	0.269	CbGeAlD
Captopril—MMP2—gall bladder—bile duct cancer	0.00446	0.061	CbGeAlD
Captopril—F2—gall bladder—bile duct cancer	0.00338	0.0463	CbGeAlD
Captopril—LTA4H—pancreas—bile duct cancer	0.00289	0.0396	CbGeAlD
Captopril—ALB—gall bladder—bile duct cancer	0.00216	0.0295	CbGeAlD
Captopril—MMP2—pancreas—bile duct cancer	0.00205	0.0281	CbGeAlD
Captopril—LTA4H—liver—bile duct cancer	0.00184	0.0252	CbGeAlD
Captopril—MMP9—pancreas—bile duct cancer	0.00179	0.0244	CbGeAlD
Captopril—REN—liver—bile duct cancer	0.00142	0.0194	CbGeAlD
Captopril—LTA4H—lymph node—bile duct cancer	0.00141	0.0193	CbGeAlD
Captopril—MMP2—liver—bile duct cancer	0.00131	0.0179	CbGeAlD
Captopril—MMP9—liver—bile duct cancer	0.00114	0.0155	CbGeAlD
Captopril—MMP2—lymph node—bile duct cancer	0.001	0.0137	CbGeAlD
Captopril—F2—liver—bile duct cancer	0.000991	0.0136	CbGeAlD
Captopril—MMP9—lymph node—bile duct cancer	0.000871	0.0119	CbGeAlD
Captopril—SLC15A1—liver—bile duct cancer	0.000845	0.0116	CbGeAlD
Captopril—ALB—liver—bile duct cancer	0.000633	0.00865	CbGeAlD
Captopril—ACE—liver—bile duct cancer	0.000606	0.00828	CbGeAlD
Captopril—MMP2—Syndecan-2-mediated signaling events—TGFB1—bile duct cancer	0.000486	0.00823	CbGpPWpGaD
Captopril—ALB—lymph node—bile duct cancer	0.000485	0.00664	CbGeAlD
Captopril—MMP2—Plasma membrane estrogen receptor signaling—NRAS—bile duct cancer	0.000471	0.00798	CbGpPWpGaD
Captopril—MMP2—EPH-ephrin mediated repulsion of cells—MMP9—bile duct cancer	0.000468	0.00793	CbGpPWpGaD
Captopril—ACE—lymph node—bile duct cancer	0.000464	0.00635	CbGeAlD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—MMP2—bile duct cancer	0.000464	0.00785	CbGpPWpGaD
Captopril—MMP9—FGF signaling pathway—MET—bile duct cancer	0.000446	0.00755	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—SMAD4—bile duct cancer	0.00043	0.00727	CbGpPWpGaD
Captopril—F2—IL1 and megakaryotyces in obesity—MMP9—bile duct cancer	0.000413	0.00699	CbGpPWpGaD
Captopril—MMP9—EPH-ephrin mediated repulsion of cells—MMP2—bile duct cancer	0.000409	0.00692	CbGpPWpGaD
Captopril—MMP2—Plasma membrane estrogen receptor signaling—KRAS—bile duct cancer	0.000406	0.00687	CbGpPWpGaD
Captopril—MMP2—amb2 Integrin signaling—IL6—bile duct cancer	0.000402	0.00681	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—HGF—bile duct cancer	0.000402	0.00681	CbGpPWpGaD
Captopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—bile duct cancer	0.000386	0.00653	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—TNC—bile duct cancer	0.000385	0.00651	CbGpPWpGaD
Captopril—MMP2—Syndecan-2-mediated signaling events—HRAS—bile duct cancer	0.000383	0.00648	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—MMP9—bile duct cancer	0.000372	0.0063	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—NOS2—bile duct cancer	0.000369	0.00625	CbGpPWpGaD
Captopril—MMP2—AGE/RAGE pathway—MMP9—bile duct cancer	0.000363	0.00615	CbGpPWpGaD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—bile duct cancer	0.000358	0.00606	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—ROBO2—bile duct cancer	0.000356	0.00602	CbGpPWpGaD
Captopril—F2—Post-translational protein modification—MUC4—bile duct cancer	0.000347	0.00588	CbGpPWpGaD
Captopril—F2—Post-translational protein modification—MUC1—bile duct cancer	0.000347	0.00588	CbGpPWpGaD
Captopril—MMP2—Plasma membrane estrogen receptor signaling—HRAS—bile duct cancer	0.000345	0.00584	CbGpPWpGaD
Captopril—LTA4H—Metabolism—IDH2—bile duct cancer	0.000338	0.00571	CbGpPWpGaD
Captopril—ABCB1—pancreas—bile duct cancer	0.000335	0.00458	CbGeAlD
Captopril—F2—Syndecan-4-mediated signaling events—MMP9—bile duct cancer	0.000328	0.00555	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—MUC4—bile duct cancer	0.000325	0.00551	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—MUC1—bile duct cancer	0.000325	0.00551	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—MMP2—bile duct cancer	0.000325	0.0055	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—MET—bile duct cancer	0.000317	0.00537	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—MMP2—bile duct cancer	0.000317	0.00536	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—bile duct cancer	0.000311	0.00527	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—NRAS—bile duct cancer	0.000309	0.00523	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—bile duct cancer	0.000305	0.00517	CbGpPWpGaD
Captopril—MMP9—Syndecan-1-mediated signaling events—TGFB1—bile duct cancer	0.000305	0.00517	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—EGFR—bile duct cancer	0.000301	0.00509	CbGpPWpGaD
Captopril—CYP2D6—liver—bile duct cancer	0.000296	0.00405	CbGeAlD
Captopril—MMP2—AGE/RAGE pathway—EGFR—bile duct cancer	0.000293	0.00497	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—MUC1—bile duct cancer	0.000292	0.00495	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—MUC4—bile duct cancer	0.000292	0.00495	CbGpPWpGaD
Captopril—LTA4H—Metabolism—IDH1—bile duct cancer	0.00029	0.00491	CbGpPWpGaD
Captopril—MMP2—Degradation of the extracellular matrix—MMP9—bile duct cancer	0.000286	0.00484	CbGpPWpGaD
Captopril—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—bile duct cancer	0.000282	0.00477	CbGpPWpGaD
Captopril—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—bile duct cancer	0.000276	0.00468	CbGpPWpGaD
Captopril—MMP2—EPH-Ephrin signaling—MMP9—bile duct cancer	0.000274	0.00463	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—bile duct cancer	0.000272	0.0046	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—KRAS—bile duct cancer	0.000266	0.0045	CbGpPWpGaD
Captopril—MMP9—amb2 Integrin signaling—IL6—bile duct cancer	0.000264	0.00447	CbGpPWpGaD
Captopril—F2—Post-translational protein modification—MUC2—bile duct cancer	0.000263	0.00445	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—TNC—bile duct cancer	0.000252	0.00427	CbGpPWpGaD
Captopril—MMP9—Degradation of the extracellular matrix—MMP2—bile duct cancer	0.000249	0.00422	CbGpPWpGaD
Captopril—MMP2—ATF-2 transcription factor network—IL6—bile duct cancer	0.000247	0.00417	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—MUC2—bile duct cancer	0.000247	0.00417	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—HRAS—bile duct cancer	0.000241	0.00409	CbGpPWpGaD
Captopril—MMP9—EPH-Ephrin signaling—MMP2—bile duct cancer	0.000239	0.00404	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—bile duct cancer	0.000235	0.00398	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—NOS2—bile duct cancer	0.000232	0.00393	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—HRAS—bile duct cancer	0.000226	0.00383	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—MUC2—bile duct cancer	0.000222	0.00375	CbGpPWpGaD
Captopril—ABCB1—liver—bile duct cancer	0.000213	0.00292	CbGeAlD
Captopril—MMP9—TWEAK Signaling Pathway—IL6—bile duct cancer	0.000212	0.00359	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—TGFB1—bile duct cancer	0.000201	0.00341	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—EGFR—bile duct cancer	0.000197	0.00334	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—EGFR—bile duct cancer	0.000192	0.00326	CbGpPWpGaD
Captopril—LTA4H—Metabolism—SLC5A5—bile duct cancer	0.000191	0.00324	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—TGFB1—bile duct cancer	0.000187	0.00317	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000179	0.00304	CbGpPWpGaD
Captopril—MMP2—EPH-Ephrin signaling—HRAS—bile duct cancer	0.000178	0.00301	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000172	0.00292	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—PTGS2—bile duct cancer	0.000171	0.00289	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—PTGS2—bile duct cancer	0.000166	0.00282	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—MUC1—bile duct cancer	0.000165	0.00279	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—MUC4—bile duct cancer	0.000165	0.00279	CbGpPWpGaD
Captopril—ABCB1—lymph node—bile duct cancer	0.000163	0.00224	CbGeAlD
Captopril—MMP2—Axon guidance—MET—bile duct cancer	0.000162	0.00275	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—EGFR—bile duct cancer	0.000161	0.00272	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—HRAS—bile duct cancer	0.000158	0.00268	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—TP53—bile duct cancer	0.000154	0.00261	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—ERBB2—bile duct cancer	0.000151	0.00256	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—SMAD4—bile duct cancer	0.000151	0.00256	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—MMP2—bile duct cancer	0.00015	0.00254	CbGpPWpGaD
Captopril—LTA4H—Metabolism—GNAS—bile duct cancer	0.000149	0.00252	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.000141	0.00239	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—IL6—bile duct cancer	0.000141	0.00239	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—IL6—bile duct cancer	0.00014	0.00238	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—TP53—bile duct cancer	0.00014	0.00237	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—TP53—bile duct cancer	0.000135	0.00228	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—SMAD4—bile duct cancer	0.000133	0.00225	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000128	0.00217	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000128	0.00217	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—HGF—bile duct cancer	0.000126	0.00214	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—MUC2—bile duct cancer	0.000125	0.00211	CbGpPWpGaD
Captopril—F2—Folate Metabolism—TP53—bile duct cancer	0.000125	0.00211	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TGFB1—bile duct cancer	0.000123	0.00209	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—EGFR—bile duct cancer	0.000121	0.00205	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—HGF—bile duct cancer	0.00012	0.00204	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—MMP9—bile duct cancer	0.00012	0.00203	CbGpPWpGaD
Captopril—MMP2—Axon guidance—ERBB2—bile duct cancer	0.000119	0.00201	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—NRAS—bile duct cancer	0.000118	0.002	CbGpPWpGaD
Captopril—MMP9—EPH-Ephrin signaling—HRAS—bile duct cancer	0.000116	0.00197	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—MET—bile duct cancer	0.000116	0.00196	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—NRAS—bile duct cancer	0.000115	0.00195	CbGpPWpGaD
Captopril—F2—Folate Metabolism—IL6—bile duct cancer	0.000114	0.00193	CbGpPWpGaD
Captopril—MMP9—Axon guidance—MET—bile duct cancer	0.000106	0.0018	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—EGFR—bile duct cancer	0.000105	0.00177	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—MMP2—bile duct cancer	0.000105	0.00177	CbGpPWpGaD
Captopril—MMP2—Axon guidance—MMP9—bile duct cancer	0.000102	0.00172	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TP53—bile duct cancer	0.000101	0.00172	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—KRAS—bile duct cancer	0.000101	0.00172	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—SMAD4—bile duct cancer	9.91e-05	0.00168	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—NOS2—bile duct cancer	9.91e-05	0.00168	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—KRAS—bile duct cancer	9.9e-05	0.00168	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—TGFB1—bile duct cancer	9.87e-05	0.00167	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IL6—bile duct cancer	9.29e-05	0.00157	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—IL6—bile duct cancer	9.07e-05	0.00154	CbGpPWpGaD
Captopril—MMP2—Axon guidance—NRAS—bile duct cancer	9.02e-05	0.00153	CbGpPWpGaD
Captopril—MMP9—Axon guidance—MMP2—bile duct cancer	8.87e-05	0.0015	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	8.76e-05	0.00148	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—HRAS—bile duct cancer	8.62e-05	0.00146	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—GNAS—bile duct cancer	8.55e-05	0.00145	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—NRAS—bile duct cancer	8.5e-05	0.00144	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—ERBB2—bile duct cancer	8.46e-05	0.00143	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—HRAS—bile duct cancer	8.42e-05	0.00143	CbGpPWpGaD
Captopril—MMP2—Axon guidance—EGFR—bile duct cancer	8.21e-05	0.00139	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—IL6—bile duct cancer	8.06e-05	0.00136	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PTGS2—bile duct cancer	7.99e-05	0.00135	CbGpPWpGaD
Captopril—MMP9—Axon guidance—ERBB2—bile duct cancer	7.77e-05	0.00132	CbGpPWpGaD
Captopril—MMP2—Axon guidance—KRAS—bile duct cancer	7.76e-05	0.00131	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—EGFR—bile duct cancer	7.74e-05	0.00131	CbGpPWpGaD
Captopril—F2—Hemostasis—GNAS—bile duct cancer	7.65e-05	0.0013	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RNF43—bile duct cancer	7.62e-05	0.00129	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MET—bile duct cancer	7.59e-05	0.00128	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—KRAS—bile duct cancer	7.32e-05	0.00124	CbGpPWpGaD
Captopril—F2—Hemostasis—HGF—bile duct cancer	7.29e-05	0.00123	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—MMP9—bile duct cancer	7.25e-05	0.00123	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—GNAS—bile duct cancer	6.81e-05	0.00115	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—MMP2—bile duct cancer	6.7e-05	0.00113	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	6.65e-05	0.00113	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—PTGS2—bile duct cancer	6.61e-05	0.00112	CbGpPWpGaD
Captopril—MMP2—Axon guidance—HRAS—bile duct cancer	6.6e-05	0.00112	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	6.51e-05	0.0011	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—TGFB1—bile duct cancer	6.47e-05	0.0011	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—NRAS—bile duct cancer	6.43e-05	0.00109	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—bile duct cancer	6.34e-05	0.00107	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MMP2—bile duct cancer	6.33e-05	0.00107	CbGpPWpGaD
Captopril—MMP2—Axon guidance—IL6—bile duct cancer	6.31e-05	0.00107	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TGFB1—bile duct cancer	5.98e-05	0.00101	CbGpPWpGaD
Captopril—MMP9—Axon guidance—NRAS—bile duct cancer	5.91e-05	0.001	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RNF43—bile duct cancer	5.88e-05	0.000996	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EGFR—bile duct cancer	5.86e-05	0.000992	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bile duct cancer	5.78e-05	0.000978	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	5.76e-05	0.000976	CbGpPWpGaD
Captopril—ALB—Metabolism—FAR2—bile duct cancer	5.72e-05	0.000968	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	5.69e-05	0.000963	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—HGF—bile duct cancer	5.61e-05	0.00095	CbGpPWpGaD
Captopril—F2—Hemostasis—NOS2—bile duct cancer	5.59e-05	0.000946	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IL6—bile duct cancer	5.57e-05	0.000943	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—ERBB2—bile duct cancer	5.55e-05	0.000939	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—KRAS—bile duct cancer	5.54e-05	0.000938	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—bile duct cancer	5.46e-05	0.000924	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	5.39e-05	0.000913	CbGpPWpGaD
Captopril—MMP9—Axon guidance—EGFR—bile duct cancer	5.39e-05	0.000912	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—TGFB1—bile duct cancer	5.15e-05	0.000873	CbGpPWpGaD
Captopril—MMP9—Axon guidance—KRAS—bile duct cancer	5.09e-05	0.000862	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—GNAS—bile duct cancer	5.05e-05	0.000856	CbGpPWpGaD
Captopril—ABCB1—Metabolism—FAR2—bile duct cancer	5.01e-05	0.000848	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TP53—bile duct cancer	4.95e-05	0.000838	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	4.91e-05	0.000831	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—GNAS—bile duct cancer	4.83e-05	0.000818	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—FAR2—bile duct cancer	4.72e-05	0.000799	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—HRAS—bile duct cancer	4.71e-05	0.000797	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	4.64e-05	0.000785	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	4.56e-05	0.000772	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL6—bile duct cancer	4.53e-05	0.000767	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—IL6—bile duct cancer	4.5e-05	0.000763	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	4.44e-05	0.000751	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—GNAS—bile duct cancer	4.39e-05	0.000743	CbGpPWpGaD
Captopril—MMP9—Axon guidance—HRAS—bile duct cancer	4.33e-05	0.000733	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—NRAS—bile duct cancer	4.22e-05	0.000715	CbGpPWpGaD
Captopril—MMP9—Axon guidance—IL6—bile duct cancer	4.14e-05	0.000701	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TGFB1—bile duct cancer	3.92e-05	0.000664	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EGFR—bile duct cancer	3.85e-05	0.000651	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—MMP2—bile duct cancer	3.77e-05	0.000639	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—KRAS—bile duct cancer	3.63e-05	0.000615	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL6—bile duct cancer	3.6e-05	0.000609	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFBR2—bile duct cancer	3.48e-05	0.00059	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	3.38e-05	0.000572	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GNAS—bile duct cancer	3.36e-05	0.000569	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SMAD4—bile duct cancer	3.3e-05	0.000558	CbGpPWpGaD
Captopril—F2—Hemostasis—NRAS—bile duct cancer	3.2e-05	0.000541	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	3.18e-05	0.000539	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	3.11e-05	0.000527	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—HRAS—bile duct cancer	3.09e-05	0.000523	CbGpPWpGaD
Captopril—ALB—Hemostasis—GNAS—bile duct cancer	3.04e-05	0.000514	CbGpPWpGaD
Captopril—F2—Hemostasis—TGFB1—bile duct cancer	2.97e-05	0.000503	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	2.96e-05	0.000502	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—IL6—bile duct cancer	2.96e-05	0.0005	CbGpPWpGaD
Captopril—ALB—Hemostasis—HGF—bile duct cancer	2.89e-05	0.00049	CbGpPWpGaD
Captopril—ALB—Metabolism—IDH2—bile duct cancer	2.79e-05	0.000473	CbGpPWpGaD
Captopril—F2—Hemostasis—KRAS—bile duct cancer	2.75e-05	0.000466	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFBR2—bile duct cancer	2.69e-05	0.000455	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.63e-05	0.000445	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GNAS—bile duct cancer	2.59e-05	0.000439	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SMAD4—bile duct cancer	2.54e-05	0.000431	CbGpPWpGaD
Captopril—ABCB1—Metabolism—IDH2—bile duct cancer	2.45e-05	0.000414	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—bile duct cancer	2.45e-05	0.000414	CbGpPWpGaD
Captopril—ALB—Metabolism—IDH1—bile duct cancer	2.4e-05	0.000406	CbGpPWpGaD
Captopril—F2—Hemostasis—HRAS—bile duct cancer	2.34e-05	0.000396	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—IDH2—bile duct cancer	2.3e-05	0.00039	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.3e-05	0.00039	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	2.29e-05	0.000387	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	2.25e-05	0.000381	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS2—bile duct cancer	2.22e-05	0.000375	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	2.21e-05	0.000374	CbGpPWpGaD
Captopril—ABCB1—Metabolism—IDH1—bile duct cancer	2.1e-05	0.000356	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	2.09e-05	0.000353	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—IDH1—bile duct cancer	1.98e-05	0.000336	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	1.85e-05	0.000314	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ERBB2—bile duct cancer	1.84e-05	0.000312	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—NRAS—bile duct cancer	1.83e-05	0.000311	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EGFR—bile duct cancer	1.67e-05	0.000283	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC5A5—bile duct cancer	1.58e-05	0.000268	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—KRAS—bile duct cancer	1.58e-05	0.000267	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.48e-05	0.000251	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ERBB2—bile duct cancer	1.42e-05	0.000241	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NRAS—bile duct cancer	1.4e-05	0.000238	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC5A5—bile duct cancer	1.39e-05	0.000235	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HRAS—bile duct cancer	1.34e-05	0.000227	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC5A5—bile duct cancer	1.31e-05	0.000221	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFB1—bile duct cancer	1.3e-05	0.000221	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—bile duct cancer	1.28e-05	0.000217	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGFR—bile duct cancer	1.28e-05	0.000216	CbGpPWpGaD
Captopril—ALB—Hemostasis—NRAS—bile duct cancer	1.27e-05	0.000215	CbGpPWpGaD
Captopril—ALB—Metabolism—GNAS—bile duct cancer	1.23e-05	0.000208	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP9—bile duct cancer	1.22e-05	0.000207	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KRAS—bile duct cancer	1.21e-05	0.000205	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB1—bile duct cancer	1.18e-05	0.0002	CbGpPWpGaD
Captopril—ALB—Hemostasis—KRAS—bile duct cancer	1.09e-05	0.000185	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NRAS—bile duct cancer	1.08e-05	0.000183	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GNAS—bile duct cancer	1.08e-05	0.000183	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—bile duct cancer	1.07e-05	0.000182	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HRAS—bile duct cancer	1.03e-05	0.000174	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GNAS—bile duct cancer	1.02e-05	0.000172	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFB1—bile duct cancer	1.01e-05	0.00017	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGFR—bile duct cancer	9.87e-06	0.000167	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—bile duct cancer	9.83e-06	0.000166	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—bile duct cancer	9.7e-06	0.000164	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KRAS—bile duct cancer	9.33e-06	0.000158	CbGpPWpGaD
Captopril—ALB—Hemostasis—HRAS—bile duct cancer	9.28e-06	0.000157	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—bile duct cancer	8.29e-06	0.00014	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HRAS—bile duct cancer	7.93e-06	0.000134	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—bile duct cancer	7.59e-06	0.000128	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—bile duct cancer	6.61e-06	0.000112	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—bile duct cancer	5.79e-06	9.8e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—bile duct cancer	5.46e-06	9.24e-05	CbGpPWpGaD
